Optimizing Outpatient Care: Clinical Strategies for Managing Hepatic Encephalopathy in Primary Practice - Episode 10

Managing Adverse Effects in HE Treatment

Published on: July 8, 2024

Pamela Kushner, MD, FAAFP , Nancy Reau, MD, Arun Jesudian, MD, Kimberly A. Brown, MD

Medical experts discuss the management of patients with hepatic encephalopathy (HE) receiving lactulose and rifaximin therapy and develop diarrhea or a urinary tract infection (UTI) in the outpatient setting.

EP. 1: Exploring the Impact of Hepatic Encephalopathy on Patients and Their Families

EP. 2: Educating Primary Care Clinicians on Outpatient HE Management and Ammonia Testing

EP. 3: HE Experts on Symptoms, Risk Factors, Diagnosis Challenges, and Severity Grading

EP. 4: Collaborating with Specialists: Primary Care Clinician’s Evolving Role in HE Management

EP. 5: Preventing Cirrhosis Progression: Gut-Liver Axis, Circulation, Inflammation

EP. 6: Hepatic Encephalopathy: Exploring Alterations in Microbiota Caused by Liver Disease

EP. 7: Current Hepatic Encephalopathy Therapies Targeting Gut-Liver Axis Disturbance

EP. 8: AASLD Guidelines for Hepatic Encephalopathy: Rifaximin's Role and Safety

EP. 9: Overview of Outpatient Strategies for Optimizing Patient Outcomes in HE

Now Viewing

EP. 10: Managing Adverse Effects in HE Treatment

EP. 11: Practical Tips for the Primary Care Clinician Treating HE

EP. 12: Refractory Encephalopathy, Multivitamins and Closing Thoughts

How do you manage a patient on lactulose and rifaximin who develops diarrhea or a UTI in the outpatient setting?